Trademark Search  /  PEPTIMIMESIS

PEPTIMIMESIS

○ Dead · Cancelled

U.S. federal trademark · Serial No. 88144687 · Reg. No. 017960616

Mark
PEPTIMIMESIS
Status
Cancelled
Serial Number
88144687
Registration No.
017960616
Filing Date
September 24, 2018
Registration Date
January 23, 2019
Class(es)
Class 001, Class 005, Class 042

Owners

Peptimimesis
99 · ILLKIRCH-GRAFFENSTADEN, FR
Peptimimesis
99 · ILLKIRCH-GRAFFENSTADEN, FR
Peptimimesis
99 · ILLKIRCH-GRAFFENSTADEN, FR

Goods & Services

Scientific research and development relating to molecules for therapeutic use; scientific research and development relating to new procedures and experiments for discovering, identifying or improving molecules for therapeutic use; scientific laboratory and engineering services for developing molecule for therapeutic use

Chemical and biological products for use in the medical and scientific research industry, namely, peptides for diagnosis or imaging in the medical and scientific research industry

Pharmaceutical and veterinary pharmaceutical preparations for purposes of treating cancer, immune disorders, central nervous system diseases, rare diseases, ophthalmic diseases, inflammatory diseases, metabolic diseases or cardiovascular diseases; Chemical preparations for pharmaceutical or medical purposes for purposes of treating cancer, immune disorders, central nervous system diseases, rare diseases, ophthalmic diseases, inflammatory diseases, metabolic diseases or cardiovascular diseases; chemical products used in the medical industry; biological preparations for use in the medical and research industry for treating cancer, immune disorders, central nervous system diseases, rare diseases, ophthalmic diseases, inflammatory diseases, metabolic diseases or cardiovascular diseases

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "PEPTIMIMESIS" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.